Taichi Takashina

Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells

Junko Kikuchi, Taichi Takashina, Ichiro Kinoshita et al. · Lung Cancer · 2012 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17

Combined inhibition of <scp>EZH</scp>2 and histone deacetylases as a potential epigenetic therapy for non‐small‐cell lung cancer cells

Taichi Takashina, Ichiro Kinoshita, Junko Kikuchi et al. · Cancer Science · 2016 · 65 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)

Gaku Yamamoto, Hajime Asahina, Osamu Honjo et al. · Scientific Reports · 2021 · 24 citations · Full text

Medicine, Oncology, Pharmacology +10

Real‐world data on the efficacy and safety of immune‐checkpoint inhibitors in elderly patients with non‐small cell lung cancer

Daisuke Morinaga, Hajime Asahina, Shotaro Ito et al. · Cancer Medicine · 2023 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report

Munehiro Matsumoto, Kentaro Nagaoka, Masaru Suzuki et al. · BMC Infectious Diseases · 2019 · 17 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17